TickerFactsScreenerDevelopers

Spyre Therapeutics, Inc. (SYRE) — Operating Income

Annual figures by fiscal year, from SEC filings.

2014: -$8.90M2015: -$11.31M2016: -$21.91M2017: -$27.68M2018: -$45.46M2019: -$80.33M2020: -$81.48M2021: -$65.65M2022: -$84.78M2023: -$242.30M2024: -$208.57M2025: -$209.56M-$209.56M
2014Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$209.56M-0.5%
2024-$208.57M+13.9%
2023-$242.30M-185.8%
2022-$84.78M-29.1%
2021-$65.65M+19.4%
2020-$81.48M-1.4%
2019-$80.33M-76.7%
2018-$45.46M-64.3%
2017-$27.68M-26.3%
2016-$21.91M-93.6%
2015-$11.31M-27.1%
2014-$8.90M—